Nov 11, 2019   SOURCE: PR NewsWire

Global Next-Generation Sequencing Market and Survey of NGS Laboratories, 2018 & 2019-2023

DUBLIN, Nov. 11, 2019 /PRNewswire/ -- The "Next-Generation Sequencing Market and Survey of NGS Laboratories" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years.

NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics.

Next-Generation Sequencing Markets provides an in-depth look at the sequencing market, including data for 2018-2023 for the following markets:

    --  Next-Generation Sequencing Market
    --  Next-Generation Sequencing Consumables Market
    --  Market Size by Application: Diagnostics
    --  Market Size by Application: Pharmaceuticals

This report includes a Survey of Labs Using Next-Generation Sequencing. The survey was conducted by an experienced NGS market analyst who interviewed lab managers and directors to obtain a real-world viewpoint on the next-generation sequencing market today.

    --  Please describe the lab's industry and function?
    --  How many sequencers does the laboratory have, and which models?
    --  For your most recent sequencers, please describe: the model, what
        applications are run typically (by percentage), how often or how many
        samples (runs, samples, slides, flow cells, plates, multiplexed or not).
    --  Which applications are expected to increase most?
    --  Does the lab outsource any sequencing? For what reason(s)?
    --  How does the lab/ organization address regulated patient samples?
    --  Does the lab have accreditation for regulated patient samples?
    --  Which sequencers are used for regulated and non-regulated patient
        samples?
    --  In what disease areas does the lab sequence regulated/ non-regulated
        patient/ human samples? What disease areas are expected to grow the most
        from 2017-2018?
    --  What percentage of samples sequenced are patient samples subject to
        regulation, patient/ human samples not subject to regulation, and
        non-patient/ non-human samples not subject to regulation? How is this
        expected to change from 2017-2018
    --  How much is the volume of NGS and capillary sequencing expected to
        change overall from 2017 to 2018?
    --  What sequencer features or steps in the sequencing process would you
        most like to be changed/ improved?
    --  What is the main bottleneck in your sequencing process (ie at what step
        do things back up)?
    --  How challenging are data analysis and data management?
    --  Which systems would the lab most likely consider for future purchases?
    --  What is the likely time-frame for future sequencer purchases?
    --  Which systems are likely to be used in the future for regulated patient
        samples (and are not being used currently for that)?
    --  What barriers or other issues would hinder the growth of sequencing,
        particularly NGS, in clinical areas?

Key Topics Covered:

1: Market Analysis and Report Summary

Overall Sequencing Market Revenue

    --  Regional Breakout
    --  Market Share

Scope
Methodology
Outline
Demographics

    --  Regional Distribution of Respondents' Labs
    --  Industrial Distribution of Respondents' Labs
    --  Laboratory Function of Respondents' Labs
    --  Distribution by Number of Sequencers
    --  Brand(s)/ Types(s) of Sequencers Owned, Overall
    --  Library Preparation and Other Automation
    --  Position/ Role of Respondents

2: System Installations

Overall Installed Base

    --  Distribution of Sequencer Models
    --  Distribution of Number of Sequencers

Installed Base by Region

    --  Overall Brand/ Type
    --  Next-Generation Systems
    --  Capillary Systems

Installed Base by Industry Segment

    --  Overall Brand/ Type
    --  Next-Generation Systems
    --  Capillary Systems

Installed Base by Laboratory Function

    --  Overall Brand/ Type
    --  Next-Generation Systems
    --  Capillary / Gel Systems

3: Sequencer Applications, Clinical Applications, and Usage Trends

Sequencer Applications and Usage

    --  Applications Run, Overall and by Brand/ Type
    --  Likely Increases in Applications and Volume
    --  Capacity Usage of Systems
    --  Outsourcing

Clinical Applications

    --  Sequencing of CLIA Regulated Patient Samples
    --  Certification for Regulated Samples
    --  Sequencers Used or Planned for Patient/ Human Samples
    --  Disease/ Therapeutic Areas Where Sequencing Applied
    --  Challenges for Growth of Clinical Sequencing

4: Preferences and Evaluations

Key Criteria for Choosing Sequencers

    --  Overall
    --  By Next-Generation Systems vs Capillary Systems

Changes or Improvements

Bottlenecks in Process

5: Future Purchase Plans

Time-Frame of Purchase Plans

    --  Overall
    --  By Brand/ Type Owned
    --  By Laboratory Function
    --  By Region

Systems Likely to Consider for Purchase

    --  Overall
    --  By Brand/ Type Owned
    --  By Industry/ Segment
    --  By Laboratory Function
    --  By Region

6: Company Profiles

    --  10x Genomics, Inc.
    --  Agilent
    --  BGI
    --  Bio-Rad Laboratories
    --  Fluidigm
    --  Illumina, Inc.
    --  MilliporeSigma
    --  Mission Bio, Inc.
    --  NanoString Technologies
    --  New England Biolabs, Inc.
    --  NuGen Technologies, Inc.
    --  Oxford Nanopore Technologies Ltd.
    --  Promega Corporation
    --  Qiagen
    --  Roche
    --  Swift Biosciences
    --  Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/hqih5z

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-next-generation-sequencing-market-and-survey-of-ngs-laboratories-2018--2019-2023-300955422.html

SOURCE Research and Markets